Literature DB >> 16872365

Extent of constitutive histone H2AX phosphorylation on Ser-139 varies in cells with different TP53 status.

T Tanaka1, A Kurose, X Huang, F Traganos, W Dai, Z Darzynkiewicz.   

Abstract

In response to DNA damage by genotoxic agents, histone H2AX is phosphorylated on Ser-139. However, during the cell cycle, predominantly in S and G(2)M phase, histone H2AX is also phosphorylated in untreated normal and tumour cells. This constitutive H2AX phosphorylation is markedly reduced by exposure of cells to the reactive oxygen species scavenger N-acetyl-L-cysteine. Therefore, it appears likely that constitutive H2AX phosphorylation reflects the ongoing oxidative DNA damage induced by the reactive oxygen species during progression through the cell cycle. Because the tumour suppressor p53 (tumour protein p53) is known to induce transcription of genes associated with cell response to oxidative stress, we have compared the intensity of constitutive H2AX phosphorylation, and the effect of N-acetyl-L-cysteine on it, in cells with different tumour protein p53 status. These were human lymphoblastoid cell lines derived from WIL2 cells: TK6, a p53 wt line, NH32, a tumour protein p53 knock-out derived from TK6, and WTK1, a WIL2-derived line that expresses a homozygous mutant of tumour protein p53. Also tested were the tumour protein p53-null promyelocytic HL-60 cells. The degree of constitutive H2AX phosphorylation was distinctly lower in NH32, WTK1 and HL-60 compared to TK6 cells in all phases of the cell cycle. Also, the degree of attenuation of constitutive H2AX phosphorylation by N-acetyl-L-cysteine was less pronounced in NH32, WTK1, and HL-60, compared to TK6 cells. However, the level of reactive oxygen species detected by the cells' ability to oxidize carboxyl-dichlorodihydrofluorescein diacetate was not significantly different in the cell lines studied, which would suggest that regardless of tumour protein p53 status, the level of oxidative DNA damage was similar. The observed higher level of constitutive H2AX phosphorylation in cells harbouring wt tumour protein p53 may thus indicate that tumour protein p53 plays a role in facilitating histone H2AX phosphorylation, an important step in the mobilization of the DNA repair machinery at the site of DNA double-strand breaks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872365      PMCID: PMC6496136          DOI: 10.1111/j.1365-2184.2006.00387.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  57 in total

1.  Structural and functional involvement of p53 in BER in vitro and in vivo.

Authors:  H Offer; M Milyavsky; N Erez; D Matas; I Zurer; C C Harris; V Rotter
Journal:  Oncogene       Date:  2001-02-01       Impact factor: 9.867

2.  DNA damage-induced activation of p53 by the checkpoint kinase Chk2.

Authors:  A Hirao; Y Y Kong; S Matsuoka; A Wakeham; J Ruland; H Yoshida; D Liu; S J Elledge; T W Mak
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

3.  A model for p53-induced apoptosis.

Authors:  K Polyak; Y Xia; J L Zweier; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

4.  Induction of DNA double-strand breaks in A549 and normal human pulmonary epithelial cells by cigarette smoke is mediated by free radicals.

Authors:  Anthony P Albino; Xuan Huang; Ellen D Jorgensen; Diana Gietl; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Int J Oncol       Date:  2006-06       Impact factor: 5.650

5.  Enhanced phosphorylation of p53 by ATM in response to DNA damage.

Authors:  S Banin; L Moyal; S Shieh; Y Taya; C W Anderson; L Chessa; N I Smorodinsky; C Prives; Y Reiss; Y Shiloh; Y Ziv
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

6.  A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.

Authors:  T T Paull; E P Rogakou; V Yamazaki; C U Kirchgessner; M Gellert; W M Bonner
Journal:  Curr Biol       Date:  2000 Jul 27-Aug 10       Impact factor: 10.834

7.  Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

Authors:  N H Chehab; A Malikzay; M Appel; T D Halazonetis
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

8.  Extension of murine life span by overexpression of catalase targeted to mitochondria.

Authors:  Samuel E Schriner; Nancy J Linford; George M Martin; Piper Treuting; Charles E Ogburn; Mary Emond; Pinar E Coskun; Warren Ladiges; Norman Wolf; Holly Van Remmen; Douglas C Wallace; Peter S Rabinovitch
Journal:  Science       Date:  2005-05-05       Impact factor: 47.728

9.  Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody.

Authors:  Olga A Sedelnikova; Emmy P Rogakou; Igor G Panyutin; William M Bonner
Journal:  Radiat Res       Date:  2002-10       Impact factor: 2.841

10.  Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer.

Authors:  Michael M Vilenchik; Alfred G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

View more
  15 in total

Review 1.  Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants.

Authors:  Toshiki Tanaka; H Dorota Halicka; Xuan Huang; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2006-09-01       Impact factor: 4.534

2.  Constitutive histone H2AX phosphorylation and ATM activation are strongly amplified during mitogenic stimulation of lymphocytes.

Authors:  T Tanaka; M Kajstura; H D Halicka; F Traganos; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

Review 3.  Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents.

Authors:  Toshiki Tanaka; Xuan Huang; H Dorota Halicka; Hong Zhao; Frank Traganos; Anthony P Albino; Wei Dai; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2007-09       Impact factor: 4.355

Review 4.  Analysis of individual molecular events of DNA damage response by flow- and image-assisted cytometry.

Authors:  Zbigniew Darzynkiewicz; Frank Traganos; Hong Zhao; H Dorota Halicka; Joanna Skommer; Donald Wlodkowic
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

5.  DNA damage signaling, impairment of cell cycle progression, and apoptosis triggered by 5-ethynyl-2'-deoxyuridine incorporated into DNA.

Authors:  Hong Zhao; H Dorota Halicka; Jiangwei Li; Ewa Biela; Krzysztof Berniak; Jurek Dobrucki; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2013-09-30       Impact factor: 4.355

6.  The Protein Tyrosine Phosphatase Activity of Eyes Absent Contributes to Tumor Angiogenesis and Tumor Growth.

Authors:  Yuhua Wang; Ram Naresh Pandey; Stephen Riffle; Hemabindu Chintala; Kathryn A Wikenheiser-Brokamp; Rashmi S Hegde
Journal:  Mol Cancer Ther       Date:  2018-05-25       Impact factor: 6.261

7.  Cytometric assessment of DNA damage by exogenous and endogenous oxidants reports aging-related processes.

Authors:  Hong Zhao; Toshiki Tanaka; H Dorota Halicka; Frank Traganos; Miroslaw Zarebski; Jurek Dobrucki; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2007-11       Impact factor: 4.355

8.  Kinetics of the UV-induced DNA damage response in relation to cell cycle phase. Correlation with DNA replication.

Authors:  Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2010-03       Impact factor: 4.355

9.  Clustering phenotype populations by genome-wide RNAi and multiparametric imaging.

Authors:  Florian Fuchs; Gregoire Pau; Dominique Kranz; Oleg Sklyar; Christoph Budjan; Sandra Steinbrink; Thomas Horn; Angelika Pedal; Wolfgang Huber; Michael Boutros
Journal:  Mol Syst Biol       Date:  2010-06-08       Impact factor: 11.429

10.  Biscoclaurine alkaloid cepharanthine protects DNA in TK6 lymphoblastoid cells from constitutive oxidative damage.

Authors:  Dorota Halicka; Masamichi Ita; Toshiki Tanaka; Akira Kurose; Zbigniew Darzynkiewicz
Journal:  Pharmacol Rep       Date:  2008 Jan-Feb       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.